Your browser doesn't support javascript.
loading
Management of chronic myeloid leukemia in children and adolescents: Recommendations from the Children's Oncology Group CML Working Group.
Athale, Uma; Hijiya, Nobuko; Patterson, Briana C; Bergsagel, John; Andolina, Jeffrey R; Bittencourt, Henrique; Schultz, Kirk R; Burke, Michael J; Redell, Michele S; Kolb, E Anders; Johnston, Donna L.
Afiliação
  • Athale U; Division of Hematology/Oncology, McMaster Children's Hospital at Hamilton Health Sciences, Hamilton, Ontario, Canada.
  • Hijiya N; Division of Hematology/Oncology, Ann and Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
  • Patterson BC; Division of Pediatric Endocrinology and Metabolism, Emory University School of Medicine, Atlanta, Georgia.
  • Bergsagel J; Division of Hematology/Oncology, Aflac Cancer and Blood Disorders Center of Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, Georgia.
  • Andolina JR; Division of Hematology/Oncology, Aflac Cancer and Blood Disorders Center of Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, Georgia.
  • Bittencourt H; Division of Hematology/Oncology, Golisano Children's Hospital, University of Rochester, Rochester, New York.
  • Schultz KR; Division of Hematology/Oncology, Ste Justine University Hospital Center, Montreal, Quebec, Canada.
  • Burke MJ; Division of Hematology/Oncology/BMT, British Columbia Children's Hospital Research Institute, Vancouver, British Columbia, Canada.
  • Redell MS; Division of Hematology/Oncology, Children's Hospital of Wisconsin, Milwaukee, Wisconsin.
  • Kolb EA; Division of Hematology/Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, Texas.
  • Johnston DL; Nemours Center for Cancer and Blood Disorders, Nemours/Alfred I DuPont Hospital for Children, Wilmington, Delaware.
Pediatr Blood Cancer ; 66(9): e27827, 2019 09.
Article em En | MEDLINE | ID: mdl-31330093
ABSTRACT
Chronic myeloid leukemia (CML) accounts for 2-3% of leukemias in children under 15 and 9% in adolescents aged 15-19. The diagnosis and management of CML in children, adolescents, and young adults have several differences compared to that in adults. This review outlines the diagnosis and management of the underlying disease as well as challenges that can occur when dealing with CML in this patient population.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mielogênica Crônica BCR-ABL Positiva Tipo de estudo: Guideline Limite: Adolescent / Child / Child, preschool / Female / Humans / Male Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mielogênica Crônica BCR-ABL Positiva Tipo de estudo: Guideline Limite: Adolescent / Child / Child, preschool / Female / Humans / Male Idioma: En Ano de publicação: 2019 Tipo de documento: Article